4,870 reports of this reaction
3.8% of all CYCLOBENZAPRINE reports
#1 most reported adverse reaction
PAIN is the #1 most commonly reported adverse reaction for CYCLOBENZAPRINE, manufactured by Cipla USA Inc.. There are 4,870 FDA adverse event reports linking CYCLOBENZAPRINE to PAIN. This represents approximately 3.8% of all 129,800 adverse event reports for this drug.
Patients taking CYCLOBENZAPRINE who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is moderately reported among CYCLOBENZAPRINE users, representing a notable but not dominant share of adverse events.
In addition to pain, the following adverse reactions have been reported for CYCLOBENZAPRINE:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 4,870 FDA reports for CYCLOBENZAPRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.8% of all adverse event reports for CYCLOBENZAPRINE, making it one of the most commonly reported side effect.
If you experience pain while taking CYCLOBENZAPRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.